Osteoarthritis Therapy Market Strategies, Top Players, Growth Opportunities, Analysis, and Forecast by 2030

The osteoarthritis therapy market size is projected to reach US$ 30,676.10 million by 2030 from US$ 17,358.64 million in 2022. The market is expected to register a CAGR of 7.4% during 2022–2030. More effective treatment options are likely to remain key trends in the market.

Osteoarthritis Therapy Market Analysis

Availability of regenerative medicine provide lucrative market opportunity in the coming years. Regenerative therapy options such as "Matrix-Induced Autologous Chondrocyte Implantation (MACI)” is one such example. MACI can repair small areas of cartilage thereby ultimately preventing or postponing OA. Further, top manufacturers are developing innovative products focussing on regenerative therapy advanced product. In September 2022, Alkem Laboratories announced receiving regulatory approval from the Drug Controller General of India (DCGI) for "StemOne" in India. "StemOne" is the first allogenic cell therapy product for commercial use for knee osteoarthritis in India. Therefore, companies launching regenerative medicine is an influential factor responsible to account considerable market growth during 2020-2030. More effective treatment options for OA is likely to remain key trends in the market.

Osteoarthritis Therapy Market Overview

Innovative therapy option thereby reducing dependency on medications to treat OA is an influential factor responsible for market growth. In osteoarthritis knee pain (OKP) treatment, knee braces are used to reduce knee pain as these braces may apply compression (pressure) to soft tissues, stabilize the knee, and redistribute weight. A few examples of knee braces are compression sleeves, hinged knee braces, and unloader knee braces. Also, these compression braces are easily available at drugstores, pharmacies, and online channels. Therefore, availability of innovative therapy options reduces dependency on medications, which drives the osteoarthritis therapy market growth in the coming decade.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Osteoarthritis Therapy Market: Strategic Insights

Osteoarthritis Therapy Market

• 
  CAGR (2022 - 2030)

  7.4%
• Market Size 2022
  US$ 17,358.64 Million
• Market Size 2030
  US$ 30,676.10 Million

Market Dynamics

GROWTH DRIVERS

• Rising Prevalence of Osteoarthritis in Emerging Economies to Favour Market
• Availability of Innovative Therapy Options Reducing Dependancy on Medications

FUTURE TRENDS

• Development of More effective treatment options are key trends in the market

OPPORTUNITIES

• Emergence of Regenerative Medicine Provide Lucrative Market Opportunity In The Coming Years

Key Players

• Vision Quest Industries Inc
• Dr. PRP USA LLC
• Estar Technologies Ltd
• Zimmer Biomet Holdings Inc
• DePuy Synthes Inc
• Bioventus Inc
• Omron Healthcare Inc
• Exactech Inc
• Medi GmbH & Co KG
• Zealmax Innovation Pvt Ltd

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Therapy Type

• TENS
• Occupational Therapy
• Physical Therapy
• Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
• Prolotherapy
• Others

Disease Indication

• Knee Osteoarthritis
• Spine Osteoarthritis
• Foot and Ankle Osteoarthritis
• Shoulder Osteoarthritis
• Hand Osteoarthritis
• Others

End User

• Hospitals and Clinics
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Osteoarthritis Therapy Market Drivers and Opportunities

Rising Prevalence of Osteoarthritis to Favour Market

Globally, OA affects more than 500 million people accounting 7% of the world's population according to the CDC report. It represents a major cause of long-term disability. Additionally, osteoarthritis is more prevalent among athletes and people who suffer from joint injury or trauma. Moreover, it is highly prevalent among women, accounting for 60% of global osteoarthritis cases. Further, the World Health Organization (WHO) report, osteoarthritis is more prevalent among older population. Thus, with the rising prevalence of OA, new therapy options such as biological therapy is gaining attention worldwide. Transcutaneous Electrical Nerve Stimulation (TENS) is an example of a treatment option to treat OA. TENS helps minimize acute and chronic pains by reducing the need for medications. Therefore, rising prevalence of OA accelerates demand for innovative treatment options, reducing the dependency on medications resulting in reduction in healthcare costs acting as one of the major drivers for global osteoarthritis therapy market share.

Availability of Regenerative Medicine Provide Lucrative Market Opportunity

Regenerative medicine is a new and potentially transformative alternative to traditional therapy options to treat OA. Regenerative medicine utilizes biomedical engineering, biomaterials, and cell therapies that target the body's immune system to treat OA. Rising inclination toward non-surgical approaches such as PRP therapy, stem cell therapy, hyaluronic acid injections, and prolotherapy would propel the adoption of regenerative medicine. Patients suffering from OA can be treated using non-pharmacological therapies however, regenerative therapy options can improve joint functions by ultimately reducing pain and enhancing the overall quality of life for individuals suffering from OA. Thus, availability of regenerative medicine is likely to create lucrative opportunities for the osteoarthritis therapy market in the coming years.

Osteoarthritis Therapy Market Report Segmentation Analysis

Key segments that contributed to the derivation of the osteoarthritis therapy market analysis are therapy type, disease indication, end user.

• Based on therapy type, the osteoarthritis therapy market is segmented as TENS, occupational therapy, physical therapy, platelet-rich plasma therapy and stromal vascular fraction, prolotherapy, and others. The physical therapy segment held a larger market share in 2022.
• By disease indication, the market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of the market in 2022.
• By end user, the market is bifurcated into hospitals and clinics, specialty clinics, ambulatory surgical centers, homecare, and others. The hospitals and clinics segment held the largest share of the market in 2022.

Osteoarthritis Therapy Market Share Analysis by Geography

The geographic scope of the Osteoarthritis Therapy market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market. In North America region, the US accounts largest share for osteoarthritis therapy market. Presence of top manufacturers in the region and their innovative technologically advanced products are the factors contributing to the dominance of the market. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Osteoarthritis Therapy Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Osteoarthritis Therapy Market News and Recent Developments

The osteoarthritis therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the osteoarthritis therapy market are listed below:

• The FDA has granted DePuy Synthes Inc 510(k) clearance for its TriLEAP Lower Extremity Anatomic Plating System, a comprehensive but modular procedure-specific system made to meet the complex needs of podiatrists, orthopaedic surgeons, and foot and ankle specialists. The TriLEAP System offers a wide range of devices that can be utilized during the reduction, internal fixation, and fusing of bones and bone fragments, as well as conventional and curved plates that can handle numerous screw diameters. (Source: DePuy Synthes Inc, Company Website, April 2022)

Osteoarthritis Therapy Market Report Coverage and Deliverables

The “Osteoarthritis Therapy Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

• Osteoarthritis therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Osteoarthritis therapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Osteoarthritis Therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Osteoarthritis Therapy market
• Detailed company profiles